Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implications.

Herzschrittmacherther Elektrophysiol · 2023 · PMC10229706 · PMID 37140824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Immunoblotting of isolated atria showed a trend towards enhanced total and activated PAR‐2 expression upon treatment with AngII, which could not be attenuated by treatment with edoxaban (Fig. 5 c,d).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.